NT$ 22.4
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very weak growth
Data is available to registered users only
Data is available to registered users only
About
Labturbo Biotech Corporation specializes in pioneering technological advancements. The company provides a range of sophisticated solutions for laboratory automation and molecular biology, which include their AIO SP-qPCR Automation System, Liquid Handling PCR Setup System, and DNA/RNA Extractor Compact Systems. Founded on June 12, 2019, its main operations are based in Taipei, Taiwan.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers.
Data is available to registered users only